Handelsbanken Fonder AB lifted its position in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 1,197.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 442,500 shares of the company’s stock after acquiring an additional 408,400 shares during the quarter. Handelsbanken Fonder AB owned 0.24% of Doximity worth $27,143,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the company. Prudential PLC purchased a new stake in Doximity during the second quarter worth $2,498,000. Main Management ETF Advisors LLC increased its position in shares of Doximity by 1.7% in the second quarter. Main Management ETF Advisors LLC now owns 14,660 shares of the company’s stock valued at $899,000 after buying an additional 240 shares in the last quarter. EFG Asset Management Americas Corp. acquired a new position in shares of Doximity during the 2nd quarter worth $1,632,000. Ensign Peak Advisors Inc boosted its position in shares of Doximity by 275.0% in the 2nd quarter. Ensign Peak Advisors Inc now owns 695,669 shares of the company’s stock worth $42,672,000 after buying an additional 510,169 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. purchased a new stake in shares of Doximity in the 2nd quarter worth about $442,000. 87.19% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Doximity
In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction dated Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total value of $1,500,000.00. Following the completion of the sale, the director owned 3,221 shares in the company, valued at $241,575. The trade was a 86.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $66.44, for a total transaction of $132,880.00. Following the transaction, the director directly owned 19,839 shares of the company’s stock, valued at approximately $1,318,103.16. This represents a 9.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 32,000 shares of company stock worth $2,339,580. 31.30% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
Check Out Our Latest Report on DOCS
Doximity Stock Performance
Shares of DOCS opened at $50.47 on Friday. Doximity, Inc. has a 1 year low of $46.04 and a 1 year high of $85.21. The company’s 50 day simple moving average is $65.37 and its 200 day simple moving average is $62.10. The company has a market capitalization of $9.50 billion, a price-to-earnings ratio of 50.47, a PEG ratio of 4.10 and a beta of 1.36.
Doximity (NASDAQ:DOCS – Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.07. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period in the prior year, the firm posted $0.30 earnings per share. Doximity’s revenue was up 23.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. Equities analysts expect that Doximity, Inc. will post 0.99 EPS for the current fiscal year.
About Doximity
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Further Reading
- Five stocks we like better than Doximity
- How to Invest in the Best Canadian Stocks
- A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves
- 3 Best Fintech Stocks for a Portfolio Boost
- 12 Analysts Just Raised CrowdStrike Targets—Here’s What They See Coming
- What is the S&P 500 and How It is Distinct from Other Indexes
- Palo Alto Networks Stock Just Pulled Back—Is This a Prime Buy Zone?
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
